Perspective Therapeutics Inc
For the period ended Dec 31, 2023. Filed Mar 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 28, 2024
CATX$0.86+1.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders’ Equity
Perspective Therapeutics, Inc. and Subsidiaries
Consolidated Statements of Changes in Stockholders' Equity
(In thousands, except shares)
| Common Stock | |||||
|---|---|---|---|---|---|
| Shares | Amount | Additional Paid-in Capital | Accumulated Deficit | Total | |
| Balances at June 30, 2021 | 141,915,266 | $142 | $158,589 | $(91,325) | $67,406 |
| Issuance of common stock pursuant to exercise of options | 125,000 | - | 56 | - | 56 |
| Share-based compensation | - | - | 1,087 | - | 1,087 |
| Net loss for the year | - | - | (7,272) | (7,272) | |
| Balances at June 30, 2022 | 142,040,266 | $142 | $159,732 | $(98,597) | $61,277 |
| Issuance of common stock pursuant to exercise of options | 72,500 | - | 28 | - | 28 |
| Share-based compensation | - | - | 672 | - | 672 |
| Net loss for the six months ended | - | - | - | (7,335) | (7,335) |
| Balances at December 31, 2022 | 142,112,766 | $142 | $160,432 | $(105,932) | $54,642 |
| Issuance of common stock in exchange for Viewpoint common stock, net of issuance costs | 136,545,075 | 137 | 54,416 | - | 54,553 |
| Assumption of Viewpoint stock options and warrants at fair value | - | - | 7,836 | - | 7,836 |
| Issuance of common stock pursuant to at the market offering, net | 1,238,826 | 1 | 363 | - | 364 |
| Issuance of common stock pursuant to exercise of options | 1,913,185 | 2 | 552 | - | 554 |
| Share-based compensation | - | - | 3,738 | - | 3,738 |
| Net loss for the year | - | - | - | (46,508) | (46,508) |
| Balances at December 31, 2023 | 281,809,852 | $282 | $227,337 | $(152,440) | $75,179 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.